blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0516787

EP0516787 - EXPRESSION SYSTEMS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.07.2001
Database last updated on 30.10.2024
Most recent event   Tooltip15.06.2007Lapse of the patent in a contracting state
New state(s): LU
published on 18.07.2007  [2007/29]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2001/24]
Former [2001/13]For all designated states
Syngenta Limited
Fernhurst
Haselmere, Surrey GU27 3JE / GB
Former [1993/48]For all designated states
ZENECA LIMITED
15 Stanhope Gate
London W1Y 6LN / GB
Former [1992/50]For all designated states
IMPERIAL CHEMICAL INDUSTRIES PLC
Imperial Chemical House, Millbank
London SW1P 3JF / GB
Inventor(s)01 / HOLLIS, Melvyn
Alderley Park
MacClesfield, Cheshire SK10 4TG / GB
02 / NEEDHAM, Maurice Ronald Charles
Alderley Park
MaMacClesfield, Cheshire SK10 4TG / GB
03 / GOODING, Clare
Alderley Park
MacClesfield, Cheshire SK10 4TG / GB
04 / GROSVELD, Franklin Geradus
Medical Research Counccil, Mill Hill
London NW7 1AD / GB
05 / ANTONIOU, Michael
Medical Research Council, Mill Hill
London NW7 1AD / GB
[1992/50]
Representative(s)Phillips, Neil Godfrey Alasdair, et al
Astra Zeneca PLC
Global Intellectual Property
Mereside
Alderley Park, Macclesfield
Cheshire SK10 4TG / GB
[N/P]
Former [1999/49]Phillips, Neil Godfrey Alasdair, et al
Astra Zeneca PLC Global Intellectual Property Mereside Alderley Park
Macclesfield Cheshire SK10 4TG / GB
Former [1999/37]Giles, David Eric, et al
AstraZeneca PLC Global Intellectual Property Mereside Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
Former [1992/50]Bill, Kevin, et al
ICI Group Legal Dept: Patents P.O. Box 6 Shire Park Bessemer Road
Welwyn Garden City Hertfordshire AL7 1HD / GB
Application number, filing date92901357.119.12.1991
[1992/50]
WO1991GB02274
Priority number, dateGB1990002791721.12.1990         Original published format: GB 9027917
[1992/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9211380
Date:09.07.1992
Language:EN
[1992/17]
Type: A1 Application with search report 
No.:EP0516787
Date:09.12.1992
Language:EN
The application published by WIPO in one of the EPO official languages on 09.07.1992 takes the place of the publication of the European patent application.
[1992/50]
Type: B1 Patent specification 
No.:EP0516787
Date:27.09.2000
Language:EN
[2000/39]
Search report(s)International search report - published on:EP09.07.1992
ClassificationIPC:C12N15/85, C12P21/02, C12N15/12, // C12N15/14, C12N15/18, C12N15/55
[1992/50]
CPC:
C07K14/7151 (EP,US); C12N15/85 (EP,KR,US); C07K14/47 (EP,US);
C07K14/61 (EP,US); C07K14/72 (EP,US); C07K14/765 (EP,US);
C07K14/805 (EP,US); C12N9/20 (EP,US); C12N2830/008 (EP,US);
C12N2830/42 (EP,US); C12N2830/85 (EP,US); C12N2840/20 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GR,   IT,   LI,   LU,   NL,   SE [1998/13]
Former [1992/50]AT,  BE,  CH,  DE,  DK,  ES,  FR,  GB,  GR,  IT,  LI,  LU,  NL,  SE 
TitleGerman:EXPRESSIONSSYSTEM[1992/50]
English:EXPRESSION SYSTEMS[1992/50]
French:SYSTEMES D'EXPRESSION[1992/50]
Entry into regional phase24.07.1992National basic fee paid 
24.07.1992Designation fee(s) paid 
24.07.1992Examination fee paid 
Examination procedure24.07.1992Examination requested  [1992/50]
07.08.1997Despatch of a communication from the examining division (Time limit: M04)
05.12.1997Reply to a communication from the examining division
16.03.1998Despatch of a communication from the examining division (Time limit: M06)
17.09.1998Reply to a communication from the examining division
23.12.1998Despatch of a communication from the examining division (Time limit: M01)
22.01.1999Reply to a communication from the examining division
09.09.1999Despatch of communication of intention to grant (Approval: Yes)
08.03.2000Communication of intention to grant the patent
15.03.2000Fee for grant paid
15.03.2000Fee for publishing/printing paid
Opposition(s)28.06.2001No opposition filed within time limit [2001/37]
Fees paidRenewal fee
12.11.1993Renewal fee patent year 03
09.11.1994Renewal fee patent year 04
08.12.1995Renewal fee patent year 05
11.12.1996Renewal fee patent year 06
12.12.1997Renewal fee patent year 07
11.12.1998Renewal fee patent year 08
09.12.1999Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.09.2000
BE27.09.2000
ES27.09.2000
GR27.09.2000
NL27.09.2000
LU19.12.2000
DK27.12.2000
SE27.12.2000
[2007/29]
Former [2004/07]AT27.09.2000
BE27.09.2000
ES27.09.2000
GR27.09.2000
NL27.09.2000
DK27.12.2000
SE27.12.2000
Former [2003/45]AT27.09.2000
BE27.09.2000
ES27.09.2000
NL27.09.2000
DK27.12.2000
SE27.12.2000
Former [2003/07]AT27.09.2000
BE27.09.2000
ES27.09.2000
NL27.09.2000
SE27.12.2000
Former [2002/25]AT27.09.2000
BE27.09.2000
ES27.09.2000
SE27.12.2000
Former [2001/37]AT27.09.2000
BE27.09.2000
SE27.12.2000
Former [2001/27]BE27.09.2000
SE27.12.2000
Former [2001/22]BE27.09.2000
Cited inInternational search[Y]EP0260148  (GENENTECH INC [US]);
 [X]WO8901517  (MEDICAL RES COUNCIL [GB]);
 [X]WO9010077  (CELLTECH LTD [GB]);
 [XP]WO9113151  (BIOGEN INC [US])
 [X]  - BIO/TECHNOLOGY vol. 8, May 1990, NEW YORK, US pages 1 - 13; H. MEADE ET AL.: 'Bovine alpha-S1-casein sequences direct high level expression of active human urokinase in mouse milk'
by applicantWO8901517
 EP0422339
    - DEISSEROTH; HENDRICK, CELL, (1978), vol. 15, pages 55 - 63
    - LAWN ET AL., CELL, (1980), vol. 21, pages 647 - 651
    - TALBOT ET AL., NATURE, (1989), page 338
    - COLLIS ET AL., EMBO JOURNAL, (1990), vol. 9, no. 1, pages 233 - 240
    - DEISSEROTH ET AL., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 72, no. 3, pages 1102 - 1106
    - GORMAN ET AL., MOLECULAR AND CELLULAR BIOLOGY, (1982), pages 1044 - 1051
    - KOZAK ET AL., MOLECULAR AND CELLULAR BIOLOGY, (1987), vol. 7, pages 3438 - 3445
    - ULMER; PALADE, PNAS, (1989), vol. 86, pages 6992 - 6996
    - KRAMER ET AL., J. BIOL. CHEM., (1989), vol. 264, pages 5768 - 5775
    - PEPINSKI ET AL., J. BIOL. CHEM., (1986), vol. 261, pages 4239 - 4246
    - SEILHAMER ET AL., J. BIOL. CHEM., (1989), vol. 264, pages 5335 - 5338
    - WEIDLE U H ET AL., GENE, (1988), vol. 66, pages 193 - 203
    - MCGROGAN ET AL., J. EXP. MED., (1988), vol. 168, pages 2295 - 2308
    - BARKER ET AL., GENE, (1990), vol. 86, pages 285 - 289
    - GLEICH ET AL., J. EXP. MED., (1974), vol. 140, pages 313 - 332
    - GRAHAM ET AL., BIOCHEMICAL & BIOPHYSICAL RESEARCH COMMUNICATIONS, (1991), vol. 177, no. 1, pages 8 - 16
    - SARGENT ET AL., PROC. NAT. ACAD. SCI., USA, (1981), vol. 78, pages 243 - 246
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.